Filtered By:
Specialty: Cardiology
Condition: Heart Failure
This page shows you your search results in order of relevance. This is page number 6.
Order by Relevance | Date
Total 4537 results found since Jan 2013.
Assessment of patients with a suspected cardioembolic ischemic stroke. A national consensus statement
Conclusions: A primary neurological and neuroradiological assessment is mandatory and neurovascular specialists should manage the initiation of secondary prophylactic treatment. If a cardioembolic stroke is suspected, a dedicated cardiologist experienced in the management of cardioembolism should provide a tailored clinical and echocardiographic assessment.PMID:34470566 | DOI:10.1080/14017431.2021.1973085
Source: Scandinavian Cardiovascular Journal - September 2, 2021 Category: Cardiology Authors: Mark Aplin Asger Andersen Axel Brandes Helena Dominguez Jordi S Dahl Dorte Damgaard Helle K Iversen Kasper K Iversen Edith Nielsen Niels Risum Michael R Schmidt Niels H Andersen Source Type: research
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
AbstractImpaired left-ventricular ejection-fraction (LV-EF) is a known risk factor for ischemic stroke and systemic embolism in patients with heart failure (HF) even in the absence of atrial fibrillation. While stroke risk is inversely correlated with LV-EF in HF patients with sinus rhythm, strategies using anticoagulation with Vitamin-K antagonists (VKA) were futile as the increase in major bleedings outweighed the potential benefit in stroke reduction. Non-Vitamin K oral anticoagulants (NOACs) proved to be an effective and in general safer approach for stroke prevention in patients with atrial fibrillation and may also h...
Source: Clinical Research in Cardiology - January 1, 2022 Category: Cardiology Source Type: research
Atrial fibrillation and stroke: importance of left atrium as assessed by echocardiography
AbstractAtrial fibrillation (AF) is the most common sustained cardiac arrhythmia, which has been increasing dramatically. AF has unfavorable consequences, such as stroke, heart failure, and cardiovascular death. Of these, stroke has been considered to be the serious complication. Recently, direct oral anticoagulation or new technologies, such as the WATCHMAN left atrium (LA) appendage closure device, have emerged to prevent stroke. Therefore, the accurate estimation of thromboembolic risk and appropriate prevention are essential for high-risk patients with AF. Although CHADS2 and CHA2DS2-VASc scores has been widely used to...
Source: Journal of Echocardiography - January 23, 2022 Category: Cardiology Source Type: research
Essen score in the prediction of cerebrovascular events compared with cardiovascular events after ischaemic stroke or transient ischaemic attack: a nationwide registry analysis
CONCLUSIONS: The Essen score is potentially more suitable for risk stratification of cardiovascular events than cerebrovascular events. Moreover, future predictive tools should take brain imaging findings and cause of stroke into consideration.PMID:35572218 | PMC:PMC9068593 | DOI:10.11909/j.issn.1671-5411.2022.04.002
Source: Atherosclerosis - May 16, 2022 Category: Cardiology Authors: Long Li Ze-Ning Jin Yue-Song Pan Jing Jing Xia Meng Yong Jiang Hao Li Cai-Xia Guo Yong-Jun Wang Source Type: research
Effect of mitral regurgitation on stroke risk in patients with non-rheumatic atrial fibrillation
CONCLUSION: In our large registry of patients with non-rheumatic AF, we did not find a protective effect of grade 3-4 MR on the risk of stroke.PMID:36030169 | DOI:10.1016/j.acvd.2022.05.006
Source: Archives of Cardiovascular Diseases - August 27, 2022 Category: Cardiology Authors: Sergio Raposeiras-Roub ín Pablo Dom ínguez-Erquicia Emad Abu-Assi Ana Ledo-Pi ñeiro Andr é González-García Carla Iglesias-Otero Enrique Garc ía-Campo Andr és Íñiguez-Romo Source Type: research
Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
The objective of this review article is to provide an overview of stroke and bleeding risk assessment in AF. There would be particular emphasis on when, how, and why to use these risk stratification schemes, with a specific focus on the CHADS2 [congestive heart failure, hypertension, age, diabetes, stroke (doubled)], CHA2DS2-VASc [congestive heart failure or left ventricular dysfunction, hypertension, age ≥75 (doubled), diabetes, stroke (doubled)-vascular disease, age 65–74 and sex category (female)], and HAS-BLED [hypertension (i.e. uncontrolled blood pressure), abnormal renal/liver function, stroke, bleeding his...
Source: European Heart Journal - April 7, 2013 Category: Cardiology Authors: Lip, G. Y. H. Tags: REVIEWS Source Type: research
Quality of Life Assessment in the Randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) Trial of Patients at Risk for Stroke With Nonvalvular Atrial Fibrillation
ConclusionsPatients with nonvalvular AF at risk for stroke treated with left atrial appendage closure have favorable QOL changes at 12 months versus patients treated with warfarin. (WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation [WATCHMAN PROTECT]; NCT00129545)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - April 22, 2013 Category: Cardiology Source Type: research
